Back to search

Article

Evaluation of a Rapid Semiquantitative Lateral Flow Assay for the Prediction of Serum Neutralizing Activity Against SARS-CoV-2 Variants

2022-04-01

Abstract excerpt

Background: Neutralizing antibodies (NAbs) against SARS-CoV-2 have been shown to strongly correlate with protection against infection. Simple tools such as lateral flow assays (LFA), that can accurately measure NAbs, will be useful for the monitoring of anti-SARS-CoV-2 immunity in the future.ObjectivesWe assessed the performance of the iChroma™ COVID-19 nAb test, a rapid semiquantitative LFA, for the prediction of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f9949d87-efea-52d9-a2c6-a69c0ce0f11b
DOI
10.2139/ssrn.4072570
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Evaluation of a Rapid Semiquantitative Lateral Flow Assay for the Prediction of Serum Neutralizing Activity Against SARS-CoV-2 VariantsDOI 10.2139/ssrn.4072570
A semi-quantitative, rapid, point of care SARS-CoV-2 serologic assay predicts neutralizing antibody levelsSemantic proximity
A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2Semantic proximity
Development and Clinical Evaluation of a Rapid Antibody Lateral Flow Assay for the Diagnosis of SARS-CoV-2 InfectionSemantic proximity
Performance of Lateral Flow Assays for SARS-CoV-2 Compared to RT-qPCRSemantic proximity
Clinical and experimental factors that affect the reported performance characteristics of rapid testing for SARS-CoV-2Semantic proximity
Exploratory study of antibody titers against SARS-CoV-2 using an indirect immunoperoxidase assay in COVID-19 patients and vaccinated volunteersSemantic proximity
Finger stick blood test to assess post vaccination SARS-CoV-2 neutralizing antibody response against variantsSemantic proximity
Comparison of a prototype SARS-CoV-2 lateral flow immunoassay with the BinaxNOW™ COVID-19 Antigen CARDSemantic proximity
IMMUNO-COV™ v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody TitersSemantic proximity
Use of the Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDsSemantic proximity
A rapid and efficient screening system for neutralizing antibodies and its application for SARS-CoV-2Semantic proximity
Boosting of Serum Neutralizing Activity Against the Omicron Variant Among Recovered COVID-19 Patients by BNT162b2 and Coronavac VaccinesSemantic proximity
Select a neighboring publication to make it the new centre.